ST316 interfered with β-catenin immune-exclusion allowing for stronger cytotoxic T-cell activity. The Food and Drug Administration (FDA) has granted Orphan Drug designation to ST316 for the treatment ...

Familial adenomatous polyposis is an inherited condition that significantly increases the risk for colon cancer. The Food and Drug Administration (FDA) has granted Orphan Drug designation to TPST-1495 ...

Recently, germline mutations in the base-excision repair gene MYH (region 1p33–34) have been described in patients with multiple adenomas, some of which had extracolonic disease (duodenal polyps).

Please provide your email address to receive an email when new articles are posted on . For patients with familial adenomatous polyposis, incidence of disease progression was not significantly lower ...

The case patient's history of mental retardation, short stature, obesity, and dysmorphic features prompted the diagnostic evaluation for PWS. PWS is a neurodevelopmental disorder caused by lack of ...

Urinary VEGF and MMP Levels As Predictive Markers of 1-Year Progression-Free Survival in Cancer Patients Treated With Radiation Therapy: A Longitudinal Study of Protein Kinetics Throughout Tumor ...

Familial adenomatous polyposis (FAP) is a hereditary disease which, in addition to carrying a high risk of bowel cancer, also greatly increases the risk of duodenal cancer. At present, the only ...

Familial adenomatous polyposis (FAP) is a hereditary disease which, in addition to a high risk of bowel cancer, also a greatly increased risk of duodenal cancer. At present, the only treatment ...

Biodexa Pharmaceuticals PLC announced the activation of its first clinical study site for the Phase 3 Serenta trial, which aims to evaluate the efficacy and safety of eRapa in treating familial ...

We thank Bhandari et al (2011) for their valuable comments on our paper (Nieuwenhuis et al, 2011). In this study, we evaluated the effectiveness of treatment in 78 patients, known at the Dutch ...

In February 2026, Recursion Pharmaceuticals reported fourth-quarter 2025 revenue of US$35.54 million, sharply higher than a ...

Researchers have developed an innovative drug treatment for familial adenomatous polyposis (FAP), a rare, inherited condition that affects adolescents and young adults and often leads to colorectal ...